Metraipolis › archive › dc_cc2e655944d4
A disproportionality analysis of FDA adverse event reporting system (FAERS) events for filgotinib — Europe PMC PMID:41396990
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41396990
- DOI
- 10.1371/journal.pone.0338188
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T15:52:07.119Z
- SHA-256 of the archived text
01555510bb2c1b7cb766cde8e39ccb4d89028f2ee63f270c9157fd3002d99151- Stable URL of this page
https://metraipolis.com/documento/dc_cc2e655944d4
How to cite
A disproportionality analysis of FDA adverse event reporting system (FAERS) events for filgotinib — Europe PMC PMID:41396990 — Europe PMC (en), https://europepmc.org/article/MED/41396990 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cc2e655944d4 (Metraipolis archive dc_cc2e655944d4, sha256 01555510bb2c1b7cb766cde8e39ccb4d89028f2ee63f270c9157fd3002d99151)
BibTeX
@misc{dccc2e655944d4,
title = {A disproportionality analysis of FDA adverse event reporting system (FAERS) events for filgotinib — Europe PMC PMID:41396990},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41396990},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cc2e655944d4; sha256 01555510bb2c1b7cb766cde8e39ccb4d89028f2ee63f270c9157fd3002d99151},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41396990. Agents can read the archived copy with the MCP tool read_document.